Feb. 18, 2021—Sabine Fuhrmann and colleagues have discovered a novel underlying cause of coloboma — a birth defect that causes missing tissue in the eye and accounts for up to 10% of childhood blindness.
Feb. 17, 2021—Vanderbilt biochemist Yi Ren is part of a team that has identified a new behavior of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens up the potential for new therapeutic targets for COVID-19.
Feb. 17, 2021—Assistant Professor of Molecular Physiology and Biophysics Gregor Neuert and Assistant Professor of Biochemistry Yi Ren have been recognized as School of Medicine Basic Sciences Dean’s Faculty Fellows. Established in 2020, the Dean’s Faculty Fellows program in Basic Sciences is designed to recognize the efforts of faculty in the early stages of their career.
Feb. 12, 2021—Bruce Carter, professor of biochemistry and an associate director of the Vanderbilt Brain Institute, has been appointed to the scientific advisory board of the CMT Research Foundation, which shapes research directions and therapeutic development of Charcot-Marie-Tooth disease.
Feb. 10, 2021—During the Research Ramp-up process, more than 3,000 Vanderbilt research personnel have returned to in-person research activities, while many others have continued remotely through perseverance and ingenuity. The efforts of the School of Medicine Basic Sciences' Charles Sanders and Vanderbilt Blair School of Music's Jeremy Wilson are highlighted.
Feb. 9, 2021—Biomedical researchers across Vanderbilt University will convene to discuss the history and impact of Black biomedical scientists on Monday, Feb. 15, at noon CT.
Feb. 4, 2021—A new method speeds the analysis of factors that control gene expression from days to minutes, allowing researchers to uncover new targets for cancer treatment.
Trans-institutional collaboration receives $2 million BRAIN Initiative grant, developing brain organoids to map neurological development
Feb. 1, 2021—Researchers will combine expertise in developmental cell biology and tissue engineering/microfluidics to develop highly complex organoids, with the goal of understanding currently incurable neurological disorders.
Jan. 27, 2021—For the second time, cancer researchers at Vanderbilt have discovered a protein that—when genetically manipulated to impede it from interacting with a gene responsible for cancer genesis—effectively melts tumors in days.
Jan. 21, 2021—William Tansey and colleagues identified proteins that interact with the cancer drug target WDR5 and are important for cancer cell growth.
Jan. 12, 2021—Discovering the mechanism behind cell behavior that is a hallmark of type 2 diabetes, Vanderbilt researchers move closer to treatments for the disease, which affects 34 million Americans.
Jan. 11, 2021—Borden Lacy, Edward and Nancy Fody Chair in Pathology and professor of biochemistry and pathology, microbiology and immunology, has been named director of the Vanderbilt Center for Structural Biology, effective Jan. 1.